HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

C&D Viviscal Deal Adds Supplement, Hair Care And E-commerce Heft

This article was originally published in The Rose Sheet

Executive Summary

The $160.4m deal reported with Lifes2Good expands the firm's play in the subscription sales space it entered with the Toppik Hair Building Fibers brand.

You may also be interested in...



Church & Dwight Spreads Specialty Play, Pays Up To $900M For Hair Removal Line

Church & Dwight purchases Flawless Finishing Touch hair removal device line for $475m from IdeaVillage Products with plan to expand distribution outside US. Firm's 12th acquisition of brand at or near top of a consumer product category, the five-device line also aligns with plan to double international business.

Church & Dwight Sees ‘A Lot Of Runway’ In US For Batiste Dry Shampoo

Market-leading Batiste is well-positioned for continued growth, given that 80% of women do not wash their hair every day and only 24% currently use dry shampoo. The brand’s US opportunity is particularly ripe, according to Executive VP and Chief Marketing Officer Britta Bohmard.

Church & Dwight Extends In Hair Care, Vitamins, Sizes Up Market For More

The health, personal and household care product firm in 2018 is adding "Naughty" and "Nice" choices to its Batiste dry shampoo line and probiotic versions of its Vitafusion adult and L'il Critter children's gummy vitamins. Both lines are among C&D's sales drivers, the 11 "power" brands that it projects nearly doubling in number through acquisitions.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109052

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel